Keystone Symposia

This meeting took place in 2014

Here are the related meetings in 2021:
Diabetes: Many Faces of the Disease (EK18)

For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

Challenges and Opportunities in Diabetes Research and Treatment (J1)

Organizer(s) Domenico Accili, Masato Kasuga and Morris F. White
January 12—17, 2014
Fairmont Hotel Vancouver • Vancouver, BC Canada
Discounted Abstract Deadline: Oct 4, 2013
Abstract Deadline: Oct 29, 2013
Scholarship Deadline: Oct 4, 2013
Discounted Registration Deadline: Nov 14, 2013

Sponsored by MedImmune, Novo Nordisk A/S, Pfizer Inc. and Takeda Pharmaceutical Company Limited

Summary of Meeting:
Type 2 diabetes affects more than 250 million people worldwide, and available therapeutic options for its treatment fall short of reversing its progressive course, let alone preventing it. This conference is focused on bringing together scientists from academia, government, and industry, to assess the state of medical discovery in areas that are likely to yield therapeutic advances for the prevention, treatment, and reversal of type 2 diabetes. The organizers have identified the following areas, among many deserving to be highlighted, for in-depth analyses and discussions: increasing energy dispersal through "browning" of white fat; metabolic effects of bariatric surgery; hormonal of hepatic lipid and glucose metabolism; integration of omics-based findings to identify biomarkers of disease predisposition and outcomes; insulin signaling and impaired beta cell function; diabetes and cancer; circadian regulation of metabolism and predisposition to diabetes; mechanisms of insulin signaling in the heart and their relationship to heart disease; and emerging therapeutic concepts in counterregulatory systems. The pace of discovery has been especially brisk in these areas, and it's likely to yield exciting new information and therapeutic advances in the foreseeable future. The conference will act as a catalyst for further progress by bringing together leaders in the academic and pharmaceutical communities to present the latest developments in their research.

View Meeting Program


National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)/National Institute on Aging (NIA) Scholarship Recipients

Gregory Baud
INSERM U859, France

Hye Rim Chang
New York University Langone Medical Center, USA

Darren C. Henstridge
Baker IDI Heart and Diabetes Institute, Australia

Jan Mauer
Max Planck Institute for Neurological Research, Germany

Isabelle Riedl
Karolinska Institutet, Sweden

Sally Yu Shi
University of Toronto, Canada

Sudhir Gopal Tattikota
Harvard Medical School, USA

The Barrie Hesp Scholarship on behalf of Ashley Rebecca Cukier Scholarship Recipients

Tsai-Hsiu Tess Lu
Max-Planck Institute of Immunobiology and Epigenetics, Germany